Elicio Therapeutics ELTX
NASDAQ ELTX
$3.08 -0.06 (-1.76%)
At close: Aug 20, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Capital Expenditures (2020 - 2026)

Elicio Therapeutics' (ELTX) quarterly Capital Expenditures came in at $225000.0 in Q1 2026, up 246.1% on a QoQ basis from -$154000.0 in Q4 2025.

Elicio Therapeutics (ELTX) Capital Expenditures (2020 - 2026) Analysis & Trends

Elicio Therapeutics (ELTX) has 7 years of Capital Expenditures data on file, last reported at $225000.0 in Q1 2026.

  • Quarterly Capital Expenditures changed N/A year-over-year to $225000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241000.0 (down 2.43% YoY) and the FY2025 annual result came in at $16000.0, down 81.61% from the prior year.
  • Capital Expenditures advanced to $225000.0 in Q1 2026, from -$154000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.3 million in Q4 2024 to a low of -$1.0 million in Q2 2024.
  • A 5-year average of $15285.7 and a median of -$12000.0 in 2022 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2022 — Capital Expenditures surged 19666.67% — and 2024, when it sank 26125.0%.
  • Tracing ELTX's Capital Expenditures over 5 years: stood at -$673000.0 in 2022, then jumped by 90.19% to -$66000.0 in 2023, then surged by 3615.15% to $2.3 million in 2024, then plunged by 106.64% to -$154000.0 in 2025, then jumped by 246.1% to $225000.0 in 2026.
  • The last three Capital Expenditures figures came in at $225000.0 (Q1 2026), -$154000.0 (Q4 2025), and $170000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 25.02 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 34.68 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 6.26 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 251.02 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -73.57 Mn
10 Elicio Therapeutics 59.08 Mn 35.58 Mn - -170,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -170,000.00
Jun 30, 2026 -170,000.00
Mar 31, 2026 225,000.00
Mar 31, 2026 225,000.00
Dec 31, 2025 -154,000.00
Dec 31, 2025 -154,000.00
Sep 30, 2025 170,000.00
Sep 30, 2025 170,000.00
Dec 31, 2024 2.32 Mn
Dec 31, 2024 2.32 Mn
Sep 30, 2024 -1.03 Mn
Sep 30, 2024 -1.03 Mn
Jun 30, 2024 -1.04 Mn
Jun 30, 2024 -1.04 Mn
Mar 31, 2024 -160,000.00
Mar 31, 2024 -160,000.00
Dec 31, 2023 -66,000.00
Dec 31, 2023 -66,000.00
Sep 30, 2023 45,000.00
Sep 30, 2023 45,000.00